Roger Jeffs
Director; Director, Chief Executive Officer · 14 filings · Latest: Jun 10, 2026
Axsome Therapeutics, Inc.
Liquidia Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AXSM | Roger Jeffs | Director | Jun 11, 2026 | Sale | $249.12 | 286 | $71.2K | 58,367 | |
AXSM | Roger Jeffs | Director | Jun 10, 2026 | Sale | $246.18 | 286 | $70.4K | 58,653 | |
AXSM | JEFFS ROGER | — | Jun 11, 2026 | Proposed Sale | $249.12 | 286 | $71.2K | — | |
AXSM | Roger Jeffs | Director | Jun 8, 2026 | Option Exercise | — | 1,429 | — | 58,939 | |
AXSM | JEFFS ROGER | — | Jun 10, 2026 | Proposed Sale | $246.18 | 286 | $70.4K | — | |
LQDA | Roger Jeffs | Director, Chief Executive Officer | May 27, 2026 | Sale | $62.18 | 6,428 | $399.7K | 1,041,667 | |
LQDA | Roger Jeffs | Director, Chief Executive Officer | May 26, 2026 | Sale | $60.38 | 25,000 | $1.5M | 1,048,095 | |
LQDA | Roger Jeffs | Director, Chief Executive Officer | May 22, 2026 | Sale | $61.52 | 25,000 | $1.5M | 1,073,095 | |
LQDA | Roger Jeffs | Director, Chief Executive Officer | May 21, 2026 | Sale | $61.13 | 25,000 | $1.5M | 1,098,095 | |
LQDA | Roger Jeffs | Director, Chief Executive Officer | May 20, 2026 | Sale | $61.30 | 25,000 | $1.5M | 1,123,095 | |
LQDA | Roger Jeffs | Director, Chief Executive Officer | May 19, 2026 | Sale | $58.65 | 25,000 | $1.5M | 1,148,095 | |
LQDA | Roger Jeffs | Director, Chief Executive Officer | May 18, 2026 | Sale | $56.77 | 25,000 | $1.4M | 1,173,095 | |
LQDA | SERENDIPITY BIOPHARMA LLC | — | May 20, 2026 | Proposed Sale | $59.98 | 106,428 | $6.4M | — | |
LQDA | Roger Jeffs | Director, Chief Executive Officer | May 15, 2026 | Sale | $57.04 | 25,000 | $1.4M | 1,198,095 | |
LQDA | Roger Jeffs | Director, Chief Executive Officer | May 14, 2026 | Sale | $58.62 | 25,000 | $1.5M | 1,223,095 | |
LQDA | Roger Jeffs | Director, Chief Executive Officer | May 13, 2026 | Sale | $56.29 | 25,000 | $1.4M | 1,248,095 | |
LQDA | SERENDIPITY BIOPHARMA LLC | — | May 14, 2026 | Proposed Sale | $57.59 | 100,000 | $5.8M | — | |
LQDA | Roger Jeffs | Director, Chief Executive Officer | May 12, 2026 | Sale | $54.04 | 25,000 | $1.4M | 1,273,095 | |
LQDA | Roger Jeffs | Director, Chief Executive Officer | May 11, 2026 | Sale | $41.50 | 25,000 | $1.0M | 1,298,095 | |
LQDA | Roger Jeffs | Director, Chief Executive Officer | May 8, 2026 | Sale | $42.14 | 25,000 | $1.1M | 1,323,095 |
Page 1 of 3
Next →